2VISONA K,BAEZ F,TAYLOR I.,et al. Impact of hepatitis B and hepatitis C virus infections in a hematologyoncology unit at a children's hospital in Nicaragua, 1997 to 1999[J]. Clin Diagn Lab Immunol, 2002,9 : 622-- 626.
3KANG J,CHO J H,SUH C W,et al. High prevalence of hepatitis B and hepatitis C virus infections in Korean patients with hematopoietic malignancies[J]. Ann Hematol, 2011,90:159--164.
4LALAZAR G, RUANG D, SHOUVAL D, et al. Screening,prevention and treatment of viral hepatitis B reactiva tion in patients with hematological malignancies[J].Br J Haematol, 2007,136:699- 712.
5LIANG R. How I treat and monitor viral hepatitis B infection in patients receiving intensive immunosuppressive therapies or undergoing hematopoietic stem cell transplantation[J].Blood, 2009,113 : 3147--3153.
6YEO W, CHANT C, LEUNG N W, et al. Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab[J]. J Clin Oncol, 2009,27 : 605 - 611.
7YAgCI M,OZKURT Z N,YFgIN Z A. Hepatitus B virus reactivation in HBV-DNA negative and positive patients with hematological malignancies [J].Hematology, 2010, 15:240--244.
8YEO W,JOHNSON P J. Diagnosis, prevention and management of hepatitis B virus reactivation during anticancer therapy. Hepatology, 2006,43 : 209 -- 220.
9ZEKRI A R N,MOHAMED W S,SAMRA M A,et al. Risk factors for cytomegalovirus, hepatitis B and C virus reactivation after bone marrow transplantation. Transpl Immunol,2004,13 : 305-- 311.
10LOCASCIULLI A,BRUNO B, ALESSANDRINO E P, et al. Hepatitis reactivation and liver failure in haemopoi- etic stem cell transplants for hepatitis B virus (HBV)/ hepatitis C virus(HCV) positive recipients : a retrospective study by the Italian group for blood and marrow transplantation[J]. Bone Marrow Transplant, 2003,31 : 295 - 300.
二级参考文献28
1Chinese Society of Hepatology and Chinese Society of Infectious Diseases,Chinese Medical Association. 42 Dongsi Xidajie,Beijing 100710,China.慢性乙型肝炎防治指南[J].中华肝脏病杂志,2005,13(12):881-891. 被引量：1931
7Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, Chinese Medical Association.肝衰竭诊疗指南[J].中华肝脏病杂志,2006,14(9):643-646. 被引量：829
1Engels EA,Cho ER,Jee SH. Hepatitis B virus infection and risk of non-Hodgkin lymphoma in south Korea:a cohort study. Lancet Oncol,201O,11(9):827-834.
2Fwu CW,Chien YC,You SL,et al. Hepatitis B virus infection and risk of intrahepatic cholangiocarcinoma and non -Hodgkin lymphoma:a cohort study of parous women in Taiwan. Hepatol?ogy,2011,53(4):1217-1225.
3KangJ, ChoJH, Suh CW, et al. High prevalence of hepatitis B and hepatitis C virus infections in Korean patients with hematopoietic malignancies. Ann Hematol, 2011 , 90( 2 ): 159-164.
4Wang F,Xu RH,Han B,et al. High incidence of hepatitis B virus infection in B -cell subtype non -Hodgkin lymphoma compared with other cancers. Cancer, 2007 , 109(7 ): 1360- 1364.
5Anderson LA, Pfeiffer R, WarrenJL, et al. Hematopoietic malig- nancies associated with viral and alcoholic hepatitis. Cancer Epidemiol Biomark Prevent,2008, I7( II ):3069-3075.
6Huang B,LiJ,Zhou Z,et al. High prevalence of hepatitis B virus infection in multiple myeloma. Leuk Lymphoma,2012,53 (2 ):270-274.
7Vladareanu AM, Ciufu C, Neagu AM, et al. The impact of hep?atitis viruses on chronic lymphoproliferative disorders -prelimi?nary results.J Med Life,2010,3(3):320-329.
8Takai S,Tsurumi H,Ando K,et al. Prevalence of hepatitis B and C virus infection in haematological malignancies and liver injury following chemotherapy. EurJ Haematol, 2005,74 (2): 158-165.
9Mirzaee M , Yaghobi R, Ramzi M , et al. The prevalence of molecular and immunologic infective markers of hepatitis viruses in patients with hematological malignancies. Mol Bio! Rep, 2012, 39( 2): 1217-1223.
10Yagci M,Ozkurt ZN, Yegin ZA,et al. Hepatitus B virus reacti?vation in HBV DNA negative and positive patients with hematological malignancies.Hematology, 20 10, 15 (4 ):240-244.
